Nauka i edukacja

Johnson & Johnson said it would buy Mentor, a maker of cosmetic products and breast implants, for $1.07 billion.

Shares of the medical device maker fell after a study showed that its new drug-coated stent was associated with more heart attacks and blood clots than a stent made by Johnson & Johnson.

The company posted higher third-quarter sales and earnings despite generic competition for certain medications and it raised its guidance for the year.

Lobbyists and executives say the swing reflects the fact that drug companies’ fortunes depend more than ever on Democrats in power.

Federal health officials said that they were reviewing a higher rate of deaths among patients treated with a Johnson & Johnson anemia drug in a German study of stroke patients.

Federal health officials said that they were reviewing a higher rate of deaths among patients treated with a Johnson & Johnson anemia drug in a German study of stroke patients.

Some lawmakers and medical groups are calling for restrictions on advertisements for medical devices like artificial knees and heart stents, claiming they mislead patients.

The company is halting some pricing practices that critics say were contributing to overuse of its flagship anemia drug Aranesp at a time of mounting concerns about the product?s safety.

The company is halting some pricing practices that critics say were contributing to overuse of its flagship anemia drug Aranesp at a time of mounting concerns about the product?s safety.

The subpoena of Johnson & Johnson broadens an investigation that has touched its competitors Abbott Laboratories and Boston Scientific.